Skip to content
AnalystLens

HCA Healthcare, Inc. 8-K Report, Corporate Update (Aug 8, 2024)

Reports
Other Events·Exhibits & Filings
Filing Date
Filed August 8, 2024
Period End
August 7, 2024
Security
HCA
In the record · 2016–202610-K1110-Q328-K144

HCA filed 11 annual reports (10-K), 32 quarterly reports (10-Q) and 144 current reports (8-K) between 2016 and 2026.

  1. Material agreement8-K · Mar ’18Mar ’18
  2. Material agreement8-K · Mar ’20Mar ’20
  3. Leadership change8-K · Aug ’22Aug ’22
  4. Leadership change8-K · Jun ’26Jun ’26

01—Abstract

Summary

Summary of the 8-K filed August 8, 2024. Cited figures are marked; the original filing is the authoritative source.

HCA Healthcare, Inc. (HCA) announced on August 7, 2024, through an 8-K filing, that it has entered into an Underwriting Agreement to issue and sell $3.0 billiona in aggregate principal amount of senior notes.

This debt offering consists of three tranches: $750 millionb of 5.450% Senior Notes due 2031, $1.25 billion of 5.450% Senior Notes due 2034, and $1.0 billion of 5.950% Senior Notes due 2054. These notes will be guaranteed on a senior unsecured basis by the Parent Guarantor, HCA Healthcare, Inc., and are being issued under the company's existing Form S-3 registration statement.

02—Key points

Key Highlights

  1. HCA Healthcare successfully priced a $3.0 billion senior notes offering.
  2. The offering is structured into three tranches with maturities in 2031, 2034, and 2054.
  3. Coupon rates for the notes are 5.450% for the 2031 and 2034 tranches, and 5.950% for the 2054 tranche.
  4. The 2031 notes are fungible and will be treated as a single series with the previously issued 5.450% Senior Notes due 2031.
  5. The issuance aims to raise capital for general corporate purposes, though specific use of proceeds is not detailed in this filing.
  6. The debt offering was facilitated through a standard Underwriting Agreement with major financial institutions, including Citigroup, BofA Securities, J.P. Morgan, and Wells Fargo.
  7. The transaction is registered under HCA's existing Form S-3 shelf registration statement.

03—Questions

Frequently Asked Questions

  1. What is the primary purpose of this 8-K filing for HCA Healthcare?

    This 8-K filing announces that HCA Healthcare has entered into an Underwriting Agreement to issue and sell $3.0 billion of senior notes. It provides details on the aggregate principal amount, the different tranches, their respective interest rates and maturity dates, and the guarantors.

  2. How will the proceeds from the $3.0 billion senior notes offering be used?

    The filing states the notes are being issued pursuant to the company's Registration Statement on Form S-3, which typically allows for the use of proceeds for general corporate purposes. However, this specific 8-K filing does not detail the exact allocation of these proceeds.

  3. What is the significance of the 2031 notes being fungible with existing notes?

    The 5.450% Senior Notes due 2031 being issued are fungible with the existing 5.450% Senior Notes due 2031. This means they will be treated as the same series of debt for all purposes under the indenture, including voting, notices, and redemptions, making the overall series of 2031 notes larger and more liquid.

  4. Does this offering indicate HCA Healthcare is facing financial difficulties or needs to refinance existing debt?

    This filing pertains to a standard debt issuance under an existing shelf registration. While debt offerings can be used for various purposes, including refinancing or funding growth initiatives, this specific filing does not provide information to suggest financial distress. It's common for large healthcare systems to access capital markets for ongoing operational needs and strategic investments.

04—Continue

← View all 8-K filings